571 related articles for article (PubMed ID: 25382490)
1. Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.
Howard K; Salkeld GP; Patel MI; Mann GJ; Pignone MP
Health Expect; 2015 Dec; 18(6):3123-35. PubMed ID: 25382490
[TBL] [Abstract][Full Text] [Related]
2. The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study.
Howard K; Salkeld GP; Mann GJ; Patel MI; Cunich M; Pignone MP
BMJ Open; 2012; 2(1):e000587. PubMed ID: 22226686
[TBL] [Abstract][Full Text] [Related]
3. Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review.
Vernooij RWM; Lytvyn L; Pardo-Hernandez H; Albarqouni L; Canelo-Aybar C; Campbell K; Agoritsas T
BMJ Open; 2018 Sep; 8(9):e025470. PubMed ID: 30185585
[TBL] [Abstract][Full Text] [Related]
4. Women's Benefits and Harms Trade-Offs in Breast Cancer Screening: Results from a Discrete-Choice Experiment.
Sicsic J; Pelletier-Fleury N; Moumjid N
Value Health; 2018 Jan; 21(1):78-88. PubMed ID: 29304944
[TBL] [Abstract][Full Text] [Related]
5. Medical Maximizing-Minimizing Preferences Predict Responses to Information about Prostate-Specific Antigen Screening.
Scherer LD; Kullgren JT; Caverly T; Scherer AM; Shaffer VA; Fagerlin A; Zikmund-Fisher BJ
Med Decis Making; 2018 Aug; 38(6):708-718. PubMed ID: 29916784
[TBL] [Abstract][Full Text] [Related]
6. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
[TBL] [Abstract][Full Text] [Related]
7. Men's preferences for prostate cancer screening: a discrete choice experiment.
de Bekker-Grob EW; Rose JM; Donkers B; Essink-Bot ML; Bangma CH; Steyerberg EW
Br J Cancer; 2013 Feb; 108(3):533-41. PubMed ID: 23361056
[TBL] [Abstract][Full Text] [Related]
8. A comparison of US and Australian men's values and preferences for PSA screening.
Howard K; Brenner AT; Lewis C; Sheridan S; Crutchfield T; Hawley S; Nielsen ME; Pignone MP
BMC Health Serv Res; 2013 Oct; 13():388. PubMed ID: 24093428
[TBL] [Abstract][Full Text] [Related]
9. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
[TBL] [Abstract][Full Text] [Related]
10. PSA testing for men at average risk of prostate cancer.
Armstrong BK; Barry MJ; Frydenberg M; Gardiner RA; Haines I; Carter SM
Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765854
[TBL] [Abstract][Full Text] [Related]
11. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
[TBL] [Abstract][Full Text] [Related]
12. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.
Flood AB; Wennberg JE; Nease RF; Fowler FJ; Ding J; Hynes LM
J Gen Intern Med; 1996 Jun; 11(6):342-9. PubMed ID: 8803740
[TBL] [Abstract][Full Text] [Related]
13. Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
Avery KN; Metcalfe C; Vedhara K; Lane JA; Davis M; Neal DE; Hamdy FC; Donovan JL; Blazeby JM
Eur Urol; 2012 Oct; 62(4):649-55. PubMed ID: 22244151
[TBL] [Abstract][Full Text] [Related]
14. The effect of information on prostate cancer screening decision process: a discrete choice experiment.
Charvin M; Launoy G; Berchi C
BMC Health Serv Res; 2020 May; 20(1):467. PubMed ID: 32456702
[TBL] [Abstract][Full Text] [Related]
15. Difference in willingness-to-pay for prostate cancer screening between ill-informed and well-informed men: a contingent valuation survey.
Yasunaga H; Sugihara T; Imamura T
Urology; 2011 Jun; 77(6):1325-9. PubMed ID: 21507471
[TBL] [Abstract][Full Text] [Related]
16. Men's Acceptance of Screening for Prostate Cancer with Prostate-specific Antigen, Magnetic Resonance Imaging, and Prostate Biopsy.
Godtman RA; Pettersson C; Svensson L; Kohestani K; Stinesen Bratt K; Wallström J; Månsson M; Hellström M; Hugosson J
Eur Urol Oncol; 2024 Jun; 7(3):553-562. PubMed ID: 37993370
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
[TBL] [Abstract][Full Text] [Related]
18. Clinicians' perceptions of the benefits and harms of prostate and colorectal cancer screening.
Elstad EA; Sutkowi-Hemstreet A; Sheridan SL; Vu M; Harris R; Reyna VF; Rini C; Earp JA; Brewer NT
Med Decis Making; 2015 May; 35(4):467-76. PubMed ID: 25637592
[TBL] [Abstract][Full Text] [Related]
19. Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experiment.
Sculpher M; Bryan S; Fry P; de Winter P; Payne H; Emberton M
BMJ; 2004 Feb; 328(7436):382. PubMed ID: 14751919
[TBL] [Abstract][Full Text] [Related]
20. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
